Results 221 to 230 of about 2,838,728 (307)
ABSTRACT Objectives J‐ENCORE is a multicenter prospective observational study in Japan involving advanced or metastatic renal cell carcinoma patients receiving nivolumab‐plus‐ipilimumab (NIVO+IPI) as first‐line treatment. The minimum 1‐year observation revealed the efficacy and safety of NIVO+IPI comparable to those in CheckMate 214, and evaluated ...
Tomokazu Sazuka +14 more
wiley +1 more source
Time-course proteomic analysis of taurocholate-induced necrotizing acute pancreatitis
Vanessa Fétaud-Lapierre +6 more
openalex +2 more sources
Effects of intraduodenally applied bile salts on pancreatic secretion [PDF]
Lehnert, Peter, Riepl, Rudolf L.
core +1 more source
ABSTRACT Background and Aim Potassium‐competitive acid blockers (P‐CABs) are a novel class of acid suppressants developed to overcome the limitations of proton pump inhibitors (PPIs), providing rapid and sustained acid suppression. While PPI‐related adverse events (AEs) are well‐documented, safety data on P‐CABs remain limited.
Yewon Jang +6 more
wiley +1 more source
IMPACT OF IMAGING METHODS ON THE DIFFERENTIAL DIAGNOSIS OF LOCAL COMPLICATIONS IN ACUTE PANCREATITIS
A. Ohanezian
openalex +2 more sources
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen +4 more
wiley +1 more source
Effect of CK2 Inhibitor in Caerulein Induced Acute Pancreatitis in a Mouse Model
Ravinder Reddy Gaddam
openalex +1 more source
Intrasplenic Pancreatic Pseudocyst: A Rare Complication of Acute Pancreatitis
Hirsh D. Trivedi +2 more
openalex +1 more source
Immediate Endoscopic Necrosectomy for Walled‐Off Pancreatic Necrosis: A First‐Choice Option?
Digestive Endoscopy, EarlyView.
Tsuyoshi Hamada +3 more
wiley +1 more source

